Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MANE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Patrick G. Enright Director | MANE Veradermics, Incorporated | Sale | 250,000 | $150.38 | $37.6M Sale | Form 4 ↗ |
| Nov 11, 2026 | Patrick G. Enright Director | MANE Veradermics, Incorporated | Sale | 250,000 | $150.38 | $37.6M Sale | Form 4 ↗ |
| Nov 11, 2026 | Longitude Capital Partners V, LLC 10% owner | MANE Veradermics, Incorporated | Sale | 250,000 | $150.38 | $37.6M Sale | Form 4 ↗ |
| Nov 11, 2026 | Longitude Capital Partners V, LLC 10% owner | MANE Veradermics, Incorporated | Sale | 250,000 | $150.38 | $37.6M Sale | Form 4 ↗ |
| Aug 19, 2026 | Averill Master Fund, Ltd. Director | MANE Veradermics, Incorporated | Sale | 59,399 | $107.25 | $6.4M Sale | Form 4 ↗ |
| Aug 19, 2026 | Averill Master Fund, Ltd. Director | MANE Veradermics, Incorporated | Sale | 690,601 | $107.25 | $74.1M Sale | Form 4 ↗ |
| Aug 17, 2026 | Timothy August Durso Chief Technical Officer | MANE Veradermics, Incorporated | Sale | 161 | $111.28 | $17.9K Sale | Form 4 ↗ |
| Aug 17, 2026 | Timothy August Durso Chief Technical Officer | MANE Veradermics, Incorporated | Sale | 2,348 | $109.34 | $256.7K Sale | Form 4 ↗ |
| Aug 17, 2026 | Timothy August Durso Chief Technical Officer | MANE Veradermics, Incorporated | Sale | 16,767 | $108.38 | $1.8M Sale | Form 4 ↗ |
| Aug 17, 2026 | Timothy August Durso Chief Technical Officer | MANE Veradermics, Incorporated | Sale | 16,306 | $107.52 | $1.8M Sale | Form 4 ↗ |
| Aug 17, 2026 | Timothy August Durso Chief Technical Officer | MANE Veradermics, Incorporated | Sale | 7,918 | $106.71 | $844.9K Sale | Form 4 ↗ |
| Aug 17, 2026 | Reid Alexander Waldman Chief Executive Officer, Director | MANE Veradermics, Incorporated | Sale | 249 | $111.28 | $27.7K Sale | Form 4 ↗ |
| Aug 17, 2026 | Reid Alexander Waldman Chief Executive Officer, Director | MANE Veradermics, Incorporated | Sale | 3,000 | $109.38 | $328.1K Sale | Form 4 ↗ |
| Aug 17, 2026 | Reid Alexander Waldman Chief Executive Officer, Director | MANE Veradermics, Incorporated | Sale | 27,490 | $108.45 | $3.0M Sale | Form 4 ↗ |
| Aug 17, 2026 | Reid Alexander Waldman Chief Executive Officer, Director | MANE Veradermics, Incorporated | Sale | 25,234 | $107.53 | $2.7M Sale | Form 4 ↗ |
| Aug 17, 2026 | Reid Alexander Waldman Chief Executive Officer, Director | MANE Veradermics, Incorporated | Sale | 11,527 | $106.72 | $1.2M Sale | Form 4 ↗ |
| Aug 12, 2026 | John W. Childs Director | MANE Veradermics, Incorporated | Sale | 5,000 | $108.24 | $541.2K Sale | Form 4 ↗ |
| Aug 12, 2026 | John W. Childs Director | MANE Veradermics, Incorporated | Sale | 80,000 | $107.23 | $8.6M Sale | Form 4 ↗ |
| Aug 12, 2026 | John W. Childs Director | MANE Veradermics, Incorporated | Sale | 15,000 | $106.14 | $1.6M Sale | Form 4 ↗ |
| Feb 6, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 19,338 | $36.55 | $706.8K Buy | Form 4 ↗ |
| Feb 6, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 11,183 | $35.97 | $402.3K Buy | Form 4 ↗ |
| Feb 5, 2026 | Vlad Coric Director | MANE Veradermics, Incorporated | Buy | 58,823 | $17.00 | $1000.0K Buy | Form 4 ↗ |
| Feb 5, 2026 | Vlad Coric Director | MANE Veradermics, Incorporated | Buy | 58,823 | $17.00 | $1000.0K Buy | Form 4 ↗ |
| Feb 5, 2026 | Longitude Venture Partners V, L.P. 10% owner | MANE Veradermics, Incorporated | Buy | 882,353 | $17.00 | $15.0M Buy | Form 4 ↗ |
| Feb 5, 2026 | Longitude Venture Partners V, L.P. 10% owner | MANE Veradermics, Incorporated | Buy | 192,647 | $17.00 | $3.3M Buy | Form 4 ↗ |
| Feb 5, 2026 | Patrick G. Enright Director, 10% owner | MANE Veradermics, Incorporated | Buy | 882,353 | $17.00 | $15.0M Buy | Form 4 ↗ |
| Feb 5, 2026 | Patrick G. Enright Director, 10% owner | MANE Veradermics, Incorporated | Buy | 192,647 | $17.00 | $3.3M Buy | Form 4 ↗ |
| Feb 5, 2026 | John W. Childs Director | MANE Veradermics, Incorporated | Buy | 294,117 | $17.00 | $5.0M Buy | Form 4/A ↗ |
| Feb 5, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 16,563 | $39.80 | $659.2K Buy | Form 4 ↗ |
| Feb 5, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 17,835 | $38.67 | $689.7K Buy | Form 4 ↗ |
| Feb 5, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 38,771 | $37.63 | $1.5M Buy | Form 4 ↗ |
| Feb 5, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 19,199 | $36.93 | $709.0K Buy | Form 4 ↗ |
| Feb 5, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 3,832 | $36.07 | $138.2K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 3,178 | $38.90 | $123.6K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 4,453 | $38.09 | $169.6K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 9,168 | $37.11 | $340.2K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 2,519 | $36.27 | $91.4K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 1,835 | $34.74 | $63.7K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 1,720 | $34.25 | $58.9K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 18,489 | $38.90 | $719.2K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 25,908 | $38.09 | $986.8K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 53,344 | $37.11 | $2.0M Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 14,659 | $36.27 | $531.7K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 10,676 | $34.74 | $370.9K Buy | Form 4 ↗ |
| Feb 4, 2026 | Suvretta Capital Management, LLC Director, 10% owner | MANE Veradermics, Incorporated | Buy | 10,004 | $34.25 | $342.6K Buy | Form 4 ↗ |
45 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances